针对三元RNA聚合酶复合物的抗流感药物:从开发到临床
Yingjun Li1,2, Jianfang Zhang2, Fengming He2
1China-Portugal Artificial Intelligence and Public Health Technologies Joint Laboratory, Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Diseases, Guangdong Provincial Key Laboratory of Respiratory Disease Research, Guangzhou Medical University, Guangzhou 510180, China.
Acta pharmaceutica Sinica. B
|February 13, 2026
概括
由于病毒的快速演变,发现新的流感抗病毒药物至关重要. 本综述详细介绍了流感聚合酶抑制剂,包括六种已批准的药物,以及它们对抗禽流感的潜力.
科学领域:
- 病毒学和分子生物学:专注于流感病毒RNA聚合酶的结构,功能和抑制.
背景情况:
- 流感病毒迅速演变,需要新的抗病毒策略.
- 流感病毒RNA聚合酶 (FluPol) 对于病毒复制至关重要,也是关键的药物标.
- 在过去的二十年里,FluPol抑制剂研究取得了重大进展.
研究的目的:
- 审查流感聚合酶的结构,功能和抑制机制.
- 突出最近批准的FluPol向抗病毒药物的发现和临床疗效.
- 评估FluPol抑制剂对高度致病性禽流感的潜力,并解决耐药性挑战.
主要方法:
- 关于流感聚合酶研究和抗病毒药物开发的综合文献综述.
- 对各种流感聚合酶抑制剂的作用机制的分析.
- 已批准和正在研究的FluPol向药物的临床数据摘要.
主要成果:
- 到2025年,六种针对FluPol的药物将获得批准,包括PA,PB1和PB2抑制剂.
- 已批准的药物包括巴洛克萨维尔马博西尔,法维皮拉维尔和昂拉迪维尔,其他药物正在临床试验中.
- 这些抑制剂证明了临床有效性,并提供了针对流感的新机制.
结论:
- 流感聚合酶抑制剂代表了抗病毒药物的关键类别.
- 已批准的药物显示出前景,正在进行的研究针对新的候选药物和耐药性.
- FluPol 抑制剂具有对抗禽流感菌株的潜力.
关键词:
抗病毒药物是一种抗病毒药物.已获批准的药物药物.药物耐药性 药物耐药性 药物耐药性流感是一次流感.聚合酶酸性蛋白质是一种聚合酶酸性蛋白质.聚合酶基础蛋白 1 1聚合酶基蛋白2的基础蛋白质有关RNA聚合酶的RNA聚合酶.复制和转录的复制和转录.基于结构的药物设计.更多相关视频
相关概念视频
Eukaryotic RNA Polymerases
27.2K
RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...
All three eukaryotic RNAPs require specific transcription factors, of which the...
27.2K
Eukaryotic RNA Polymerases
9.6K
9.6K
Bacterial RNA Polymerase
32.9K
Unlike eukaryotes, bacteria use a single RNA Polymerase (RNAP) to transcribe all genes. The different subunits of bacterial RNAPhave distinct functions. The multisubunit structure of the bacterial RNAP helps the enzyme to maintain catalytic function, facilitate assembly, interact with DNA and RNA, and self-regulate its activity.
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
32.9K
Bacterial RNA Polymerase
12.1K
12.1K
RNA Polymerase II Accessory Proteins
11.1K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
11.1K
RNA Polymerase II Accessory Proteins
4.1K
4.1K


